News
7h
GlobalData on MSNBrainStorm Cell Therapeutics and Minaris partner on manufacturing NurOwn for trialUS-based biotechnology company BrainStorm Cell Therapeutics has partnered with contract development and manufacturing ...
The Education & Research (NUCSER), a constituent college of Nitte University is part of a prestigious academic ecosystem. Nitte University is accredited with an A+ Grade by NAAC, ranked 66 in the NIRF ...
Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced that the results from the open label Phase 2 PROSPECT Study of tirabrutinib is to be ...
Mumbai's most progressive and multidisciplinary private university, is now accepting applications for its undergraduate ...
6d
The Pioneer on MSNRanchi girl Kanika Anabh gets AIR 1 in Indian Forest Service ExamYour support to NYOOOZ will help us to continue create and publish news for and from smaller cities, which also need equal voice as much as citizens living in bigger cities have through mainstream ...
2d
Interesting Engineering on MSNAtomic riddle solved: Carbyne emerges as powerful quantum sensor after nearly a decadeResearchers have resolved a puzzling vibrational phenomenon that has baffled the scientific community for years, after ...
The researchers note that a key feature of the study was the use of a standardized daily spontaneous breathing trial (SBT) in ...
Feig and her team from the Department of Mechanical Engineering at Stanford University developed the Self-Aggregating ...
MSC Industrial Direct ( MSC) was upgraded to Overweight from a previous investment rating of Neutral by analysts at financial-services firm J.P. Morgan. They pointed to the potential benefits of ...
Jawaharlal Nehru University has opened postgraduate admissions for the 2025 academic year, accepting applications until June ...
Jawaharlal Nehru University has opened applications for its 2025 PG programs. Last date to register on jnuee.jnu.ac.in is June 16.
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that it has signed a Letter of Intent (LOI) with Minaris Advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results